http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103279668-B

Outgoing Links

Predicate Object
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G06F19-00
filingDate 2013-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2016-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2016-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-103279668-B
titleOfInvention A kind of quantitative evaluation system of concurrent chemoradiotherapy of malignant tumor specification degree of conformity
abstract The invention discloses a kind of quantitative evaluation system of concurrent chemoradiotherapy of malignant tumor specification degree of conformity, first, define the general frame of concurrent chemoradiotherapy of malignant tumor specification degree of conformity quantitative evaluation system; Secondly, formulate the database establishment method of concurrent chemoradiotherapy of malignant tumor specification degree of conformity quantitative evaluation system, comprise the building method of concurrent chemoradiotherapy of malignant tumor diagnosis and treatment normative database, medicine knowledge base and case database, be convenient to assess the specification degree of conformity of concurrent chemoradiotherapy of malignant tumor and manage; Finally, for being difficult to the special case carrying out chemoradiotherapy standard conformity quantitative evaluation, formulate the quantitative evaluation that a kind of Expert Evaluation System carrys out chemoradiation therapy specification degree of conformity.
priorityDate 2013-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID176870
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505536
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123631
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407319186

Total number of triples: 13.